OncoSec Medical Incorporated (ONCS) |
|
2.15 0.02 (0.94%)
|
10-15 10:02 |
|
Open: |
2.12 |
Pre. Close: |
2.13 |
|
High:
|
2.21 |
Low:
|
2.06 |
|
Volume:
|
41,420 |
Market Cap:
|
23M |
|
|
|
|
OncoSec Medical Inc is a biotechnology company engaged in designing, developing and commercializing gene therapies, therapeutics and proprietary medical approaches to stimulate and guide an anti-tumor immune response for the treatment of cancer. |
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
2.152 - 2.167 |
2.167 - 2.179 |
|
Low:
|
2.012 - 2.028 |
2.028 - 2.04 |
|
Close:
|
2.109 - 2.134 |
2.134 - 2.153 |
|
Technical analysis |
as of: 2019-10-14 4:48:12 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 2.80 One year: 3.27 |
| Support: |
Support1: 1.91 Support2: 1.60 |
| Resistance: |
Resistance1: 2.40 Resistance2: 2.80 |
| Pivot: |
1.94  |
| Moving Average: |
MA(5): 1.96 MA(20): 2.00
MA(100): 2.24  MA(250): 5.44 |
| MACD: |
MACD(12,26): -0.02 Signal(9): -0.04 |
| Stochastic oscillator: |
%K(14,3): 79.05 %D(3): 56.02 |
| RSI: |
RSI(14): 56.30 |
| 52-week: |
High: 19.60 Low: 1.60 Change(%): -85.9 |
| Average Vol(K): |
3-Month: 27538 10-Days: 127458 |
|
Price, moving averages and Bollinger Bands |
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.ONCS has closed below upper band by 19.5%. Bollinger Bands are 30% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Headline News |
2019-06-07
Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix
Zacks.com featured highlights include: HP, Party City, AbbVie, OncoSec Medical and Pulmatrix
2019-05-29
OncoSec to commercialize TAVO in Australia/New Zealand
No summary available.
|
Financial Analysis |
| Growth |
 |
| Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing. |
| Profitability |
 |
| Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs. |
| Solvency |
 |
| Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry. |
| Efficiency |
|
| Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not. |
| Click here to get more fundamental analysis.
|
|
|
|
